Where Will TC BioPharm Ltd (TCBP) Stock Go Next After It Is Higher By 11.73% in a Week?

Overall market sentiment has been down on TC BioPharm Ltd (TCBP) stock lately. TCBP receives a Bearish rating from InvestorsObserver Stock Sentiment Indicator.

TC BioPharm Ltd has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on TCBP!

See Full TCBP Report

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down. InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend. Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With TCBP Stock Today?

TC BioPharm Ltd (TCBP) stock is trading at $5.81 as of 3:43 PM on Thursday, Jan 26, a gain of $1.76, or 43.46% from the previous closing price of $4.05. The stock has traded between $4.25 and $6.09 so far today. Volume today is elevated. So far 4,161,334 shares have traded compared to average volume of 1,614,558 shares.

More About TC BioPharm Ltd

TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. Click Here to get the full Stock Report for TC BioPharm Ltd stock.